Overview

Study of Oral Vinorelbine and Erlotinib in Non-Small Cell Lung Cancer

Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to define the schedule and dose of oral vinorelbine (Navelbine) to be used with erlotinib in non-small cell lung cancer.
Phase:
Phase 1
Details
Lead Sponsor:
National Cancer Centre, Singapore
Treatments:
Erlotinib Hydrochloride
Vinblastine
Vinorelbine